DE154353T1 - Anti-gedaechtnisschwund-mittel. - Google Patents

Anti-gedaechtnisschwund-mittel.

Info

Publication number
DE154353T1
DE154353T1 DE198585102668T DE85102668T DE154353T1 DE 154353 T1 DE154353 T1 DE 154353T1 DE 198585102668 T DE198585102668 T DE 198585102668T DE 85102668 T DE85102668 T DE 85102668T DE 154353 T1 DE154353 T1 DE 154353T1
Authority
DE
Germany
Prior art keywords
amino acid
general formula
group
denotes
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198585102668T
Other languages
German (de)
English (en)
Inventor
Hisao Hagiwara
Kunio Minato-Ku Tokyo Kado
Daisuke Tsuru
Tadashi Nagasaki-Shi Nagasaki-Ken Yoshimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of DE154353T1 publication Critical patent/DE154353T1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE198585102668T 1984-03-09 1985-03-08 Anti-gedaechtnisschwund-mittel. Pending DE154353T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59043751A JPS60188317A (ja) 1984-03-09 1984-03-09 抗健忘症剤

Publications (1)

Publication Number Publication Date
DE154353T1 true DE154353T1 (de) 1986-04-10

Family

ID=12672465

Family Applications (2)

Application Number Title Priority Date Filing Date
DE198585102668T Pending DE154353T1 (de) 1984-03-09 1985-03-08 Anti-gedaechtnisschwund-mittel.
DE8585102668T Expired DE3574251D1 (en) 1984-03-09 1985-03-08 An anti-amnestic agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8585102668T Expired DE3574251D1 (en) 1984-03-09 1985-03-08 An anti-amnestic agent

Country Status (5)

Country Link
US (1) US4687778A (cg-RX-API-DMAC7.html)
EP (1) EP0154353B1 (cg-RX-API-DMAC7.html)
JP (1) JPS60188317A (cg-RX-API-DMAC7.html)
CA (1) CA1237987A (cg-RX-API-DMAC7.html)
DE (2) DE154353T1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0623191B2 (ja) * 1985-04-16 1994-03-30 サントリー株式会社 ペプチダ−ゼ阻害活性化合物およびその製法ならびに用途
CA1298033C (en) * 1985-04-16 1992-03-24 Takaharu Tanaka Dipeptide derivative of fatty acid
CA1309805C (en) * 1985-04-16 1992-11-03 Naoki Higuchi Dipeptide derivative and synthesis and use thereof
JPH0651677B2 (ja) * 1985-12-23 1994-07-06 サントリー株式会社 ジペプチド誘導体及びその製法並びに用途
JPH0611754B2 (ja) * 1985-10-09 1994-02-16 サントリー株式会社 ペプチダ−ゼ阻害作用を有する新規化合物及びその製法並びに用途
JPH0764834B2 (ja) * 1985-11-29 1995-07-12 サントリー株式会社 プロリルエンドペプチダーゼ阻害活性を有する新規ピロリジンアミド誘導体およびその製法並びに用途
CA1320734C (en) * 1986-02-04 1993-07-27 Suntory Limited Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same
US5198458A (en) * 1986-02-04 1993-03-30 Suntory Limited Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same
US4880827A (en) * 1986-03-18 1989-11-14 Sumitomo Pharmaceuticals Company, Ltd. Pyrrolidine derivatives having inhibitory action for proline specific endopepidase
JPH08806B2 (ja) * 1986-11-18 1996-01-10 サントリー株式会社 プロリルエンドペプチダ−ゼ阻害作用を有する新規ピロリジンアミド誘導体
DE3786229T2 (de) * 1986-11-20 1993-10-07 Ono Pharmaceutical Co Prolinalderivate.
US5254550A (en) * 1986-11-20 1993-10-19 Ono Pharmaceutical Co., Ltd. Prolinal derivatives and pharmaceutical compositions thereof
ES2054712T3 (es) * 1987-02-04 1994-08-16 Ono Pharmaceutical Co Un procedimiento para la preparacion de los derivados de prolinal.
ES2103287T3 (es) * 1987-02-23 1997-09-16 Ono Pharmaceutical Co Nuevos derivados de tiazolidina.
US5043348A (en) * 1987-04-24 1991-08-27 Cassella Aktiengesellschaft Pyrrolealdehydes, their preparation and their use
JP2515568B2 (ja) * 1987-12-25 1996-07-10 株式会社ヤクルト本社 新規なチアゾリジン誘導体
CA1335079C (en) * 1988-07-25 1995-04-04 Kiyoshi Takatsuki Preventive and curative agents for acquired immune deficiency syndrome (aids)
JP2691442B2 (ja) * 1989-02-20 1997-12-17 株式会社ヤクルト本社 新規なプロリン誘導体
WO1990012005A1 (fr) * 1989-04-13 1990-10-18 Japan Tobacco Inc. Nouveaux derives aminoacides possedant une activite d'inhibiteur de la prolylendopeptidase
US5506256A (en) * 1990-07-27 1996-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Proline derivatives possessing prolyl endopeptidase-inhibitory activity
WO2006058720A2 (en) * 2003-11-03 2006-06-08 Probiodrug Ag Novel compounds for the treatment of neurological disorders
US7667044B2 (en) 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
JP2008521853A (ja) * 2004-12-02 2008-06-26 プロビオドルグ エージー 神経疾患治療用の新規化合物

Also Published As

Publication number Publication date
EP0154353A3 (en) 1986-01-22
DE3574251D1 (en) 1989-12-21
EP0154353A2 (en) 1985-09-11
JPH0419208B2 (cg-RX-API-DMAC7.html) 1992-03-30
EP0154353B1 (en) 1989-11-15
US4687778A (en) 1987-08-18
CA1237987A (en) 1988-06-14
JPS60188317A (ja) 1985-09-25

Similar Documents

Publication Publication Date Title
DE154353T1 (de) Anti-gedaechtnisschwund-mittel.
DE69131847T2 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE60130192T2 (de) Kahalalide f und verwandte verbindungen
DE3588095T2 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
DK326885D0 (da) Fluorescerende mono-, di- eller polyamider og fremgangsmaade til fremstilling heraf
WO1995030687A1 (de) Neurokinin (tachykinin)-antagonisten
CH617667A5 (cg-RX-API-DMAC7.html)
EP0034259A1 (de) Peptidester, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel beziehungsweise Diagnostica
EP0067425A1 (de) Gegebenenfalls geschützte Peptide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2616399A1 (de) Polypeptid und verfahren zu seiner herstellung
DD207708A5 (de) Verfahren zur herstellung von neuen cyclischen octapeptiden
CH633523A5 (de) Verfahren zur herstellung von peptiden und peptidderivaten.
DE3751586T2 (de) Antitumor-Aminosäuren und Peptid-Derivate von 1,4-bis[(Aminoalkyl und Hydroxyaminoalkyl)amino]5,8-Dihydroxyanthraquinonen.
DE3117948C2 (de) Tripeptide und diese Verbindungen enthaltende Arzneimittel
EP0176070B1 (de) Pharmakologisch aktive peptide
DE68923592T2 (de) HIV Protease-Hemmer.
WO1981000712A1 (fr) Peptides pharmacologiquement actifs et medicaments les contenant
ATE89264T1 (de) Arzneimittel enthaltend nitroxyalkylamine mit amidfunktion und verfahren zur herstellung dieser verbindungen.
DE69116772T2 (de) Peptid oder seine Salze
DE2633976A1 (de) Tripeptidderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE2726849A1 (de) Dihydro- und tetrahydro-iminothiazine
EP0137339B1 (de) Pharmakologisch aktive Peptide
DE2723453C2 (de) 1-Desamino-asparagin↑4↑-D-arginin↑8↑-vasopressin, Verfahren zu seiner Herstellung sowie dieses Peptid enthaltende antidiuretische Arzneimittel
DE69120247T2 (de) Peptidverbindungen von linksdrehenden aminosäuren und ringmolekülen, und therapeutische anwendung davon
DE1916481B2 (de) Hydroxylamindenväte und Arzneimittel, die diese Verbindungen enthalten